Plan estratégico de responsabilidad social empresarial en la IPS Renacerá de la ciudad de Villavicencio, Meta

https://www.canva.com/design/DAEwefP5kUw/share/preview?token=2PXBhVFGvqdijBTx5cVVnA&role=EDITOR&utm_content=DAEwefP5kUw&utm_campaign=designshare&utm_medium=link&utm_source=sharebuttonLa RSE se rige bajo la norma ISO 26000, en la cual, se constituyen los compromisos y deberes que deben adquirir las organizaciones, para contrarrestar los impactos en el medio ambiente y en la sociedad, es por ello, que la norma busca establecer sistemas de responsabilidad social en todas las organizaciones para que mejoren los procesos y la participación en actividades de la RSE. Para esta investigación, se realiza un estudio observacional de corte cualitativo interpretativo, diseñando un modelo de aplicación de la norma antes mencionada, así mismo, la base de información para esta investigación, fueron fuentes primarias con visitas de campo por parte del grupo investigador y la aplicación del modelo diseñado basado en la norma ISO 26000, a la Gerencia y a la oficina de Talento Humano de la IPS. También, se recopila evidencia documental disponible que facilitó la IPS objeto de estudio. Así las cosas, el diagnostico principal es la escasa participación de los grupos de interés, por lo tanto, se diseña un plan estratégico empresarial para la IPS Renacerá con el fin de mejorar la participación de los grupos de interés (stakeholders) en las actividades de la RSE, dicho plan de acción y seguimiento, se enfoca en las tres dimensiones de la RSE, cada una con sus respectivos objetivos y estrategias que permitan hacer seguimiento oportuno a los procesos y metas que establezca la organización. Es oportuno indicar, que se busca de manera primordial estrategias seguras de cooperación de los grupos de interés, obteniendo que las acciones realizadas sean valoradas y acatadas por la IPS, permitiendo resultados efectivos en todas las estrategias diseñadas para cumplir con los objetivos propuestos por la norma ISO 26000.CSR is governed by the ISO 26000 standard, which establishes the commitments and duties that organizations must acquire to counteract the impacts on the environment and society, which is why the standard seeks to establish social responsibility systems in all organizations to improve processes and participation in CSR activities. For this research, an interpretative qualitative observational study was conducted, designing a model for the application of the aforementioned standard. Likewise, the information base for this research were primary sources with field visits by the research group and the application of the model designed based on the ISO 26000 standard, to the Management and the Human Resources office of the IPS. Also, available documentary evidence provided by the IPS under study was compiled. Therefore, a strategic business plan is designed for IPS Renacerá in order to improve the participation of stakeholders in CSR activities. This action and monitoring plan focuses on the three dimensions of CSR, each with their respective objectives and strategies that allow for timely monitoring of the processes and goals established by the organization. It is appropriate to indicate that the main objective is to seek safe strategies of cooperation with stakeholders, ensuring that the actions taken are valued and complied with by the IPS, allowing effective results in all strategies designed to meet the objectives proposed by the ISO 26000 standard

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN